David J Benjamin
Overview
Explore the profile of David J Benjamin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
280
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hsu R, Arter Z, Benjamin D
JCO Glob Oncol
. 2025 Feb;
11:e2400656.
PMID: 40014842
No abstract available.
2.
Grande E, Hussain S, Barthelemy P, Kanesvaran R, Giannatempo P, Benjamin D, et al.
Cancer Treat Rev
. 2025 Feb;
134:102900.
PMID: 39999590
The treatment landscape for patients with advanced urothelial carcinoma (UC) has evolved rapidly in recent years. In current guidelines, combination treatment with enfortumab vedotin plus pembrolizumab is the first-line (1L)...
3.
Benjamin D, Kalebasty A
Urology
. 2025 Feb;
PMID: 39983787
Objective: To characterize the genitourinary medical oncology workforce in the United States. Methods: Utilizing the top cancer hospitals as ranked by US News & World Reports, genitourinary medical oncologists in...
4.
Benjamin D, Von Hoff D
Cancer Drug Resist
. 2025 Feb;
7:49.
PMID: 39931650
With the growing incidence of obesity-related malignancies, glucagon-like peptide-1 (GLP-1) receptor agonists represent an intriguing potential clinical avenue for cancer prevention and treatment. Population-based data suggest that individuals who have...
5.
Hasan N, Yazdanpanah O, Khaleghi B, Benjamin D, Kalebasty A
Cancer Treat Res Commun
. 2025 Feb;
43:100876.
PMID: 39922003
Goal Of The Review: The objective of this review is to conduct a thorough examination of the current evidence regarding the correlation between dietary sugar intake and cancer risk. This...
6.
Benjamin D, Hsu R
Front Oncol
. 2025 Jan;
14:1457006.
PMID: 39882447
Penile cancer is a rare genitourinary malignancy which can be treated with surgery or radiation for localized disease, but often requires systemic treatment with chemotherapy for recurrent or metastatic disease....
7.
Benjamin D, Kalebasty A, Mar N
Eur Urol Oncol
. 2025 Jan;
PMID: 39855979
The recent withdrawal of sacituzumab govitecan for advanced urothelial carcinoma has revealed several implications, including concerns over a lack of remaining effective treatment options, reimbursement, supportive care measures (such as...
8.
Benjamin D, Adeyelu T, Elliott A, Darabi S, Lee T, McKay R, et al.
NPJ Precis Oncol
. 2025 Jan;
9(1):12.
PMID: 39799194
Urachal cancer, a rare malignancy, generally presents in the clinical setting with advanced stages of disease. Systemic treatment with chemotherapy is generally utilized in this setting. However, there remains a...
9.
Benjamin D, Shrestha A, Fellman D, Kalebasty A
BJUI Compass
. 2025 Jan;
5(12):1249-1251.
PMID: 39744080
No abstract available.
10.
Mahadevan A, Yazdanpanah O, Patel V, Benjamin D, Kalebasty A
Curr Probl Cancer
. 2024 Dec;
54():101171.
PMID: 39708456
Genitourinary cancers affect over 480,000 patients in the United States annually. While promising therapeutic modalities continue to emerge, notably immune checkpoint inhibitors, molecular targeted therapies, antibody-drug conjugates, and radioligand therapies,...